ICH GUIDELINE FOR STABILITY TESTING
·
Describes regarding sampling times, storage conditions&
specific test parameters for each dosage form.
·
The FDA & The expert working group of the ICH of
technical requirements for the registration of pharmaceuticals for human use
have published guidelines for conducting the actual studies.
·
ICH guideline as follow,
o Quality
Guidelines “Q” (chemical and pharmaceutical QA)
o Safety
Guidelines “S” (in vitro and in vivo pre-clinical studies)
§ covering
Carcinogenicity Testing, Genotoxicity Testing,
§ Toxicokinetics
and Pharmacokinetics ….. etc.
o Efficacy
Guidelines “E” (clinical studies in human subject)
§ Covering
clinical safety, Dose Response Studies, Good
§ Clinical
Practices, Clinical evaluation …. etc.
o Multidisciplinary
Guidelines “M”
§ Covering
Medical Terminology, Electronic Standards for
§ Transmission
of Regulatory Information …… etc.
§ Important
for Stability
§ Guideline
M4: The Common Technical Document (CTD)
ICH Guideline “Q”:
·
Stability Testing (Q1)
o Stability
Testing in Climatic Zone I and II (Q1A)
§ Stability testing
protocol including temperature, humidity and trial duration.
o Photo
stability Testing (Q1B)
§ Protocol required
to evaluate light sensitivity and stability of New substances.
o Stability
Testing for New Dosage Forms (Q1C)
§ Main stability
guideline for new formulation & stability data required.
§ General principle
to reduce stability testing & provide example.
o Evaluation
of Stability Data (Q1E)
§ Statistical
approach to stability data analysis
o Stability
Testing in Climatic Zones III and IV (Q1F)
§ Acceptable storage
condition
·
Validation of Analytical Procedures (Q2)
·
Impurities (Q3)
·
Pharmacopoeial Harmonization (Q4)
·
Biotechnological Products (Q5)
Specifications (Q6)
Comments
Post a Comment